Xcision Medical Systems said that its GammaPod breast cancer treatment system has received the CE Mark. The stereotactic radiotherapy system gained FDA clearance in 2017. The therapy differs from conventional techniques in that it delivers higher doses of more focused radiation in fewer treatments. GammaPod may also enable patients receiving whole-breast irradiation with a tumor…
The post Xcision Medical’s breast cancer treatment wins CE Mark appeared first on Medical Design and Outsourcing.